MedPath

Corneal Endothelium Cell Loss After Cataract Extraction in Patients Taking Tamsulosin

Completed
Conditions
Cataract
Registration Number
NCT01076309
Lead Sponsor
Frederiksberg University Hospital
Brief Summary

The purpose of this study is to determine whether corneal endothelium cell loss during cataract surgery is higher in patients taking Tamsulosin.

Detailed Description

Cataract surgery in patients taking Tamsulosin is regarded as more challenging for the surgeon because Intraoperative Floppy Iris Syndrome (IFIS) might occur. However, the question is whether this has any practical implication for the outcomes of surgery. In this study we investigate whether cornea is damage during surgery on Tamsulosin patient. In an observational study 30 cataract patients taking Tamsulosin is compared to 30 patients not taking Tamsulosin, but otherwise similar. Number of patients is based on power calculation.

Cornea is examined by specular microscopy.

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
60
Inclusion Criteria
  • cataract needing surgery
Exclusion Criteria
  • glaucoma
  • corneal scarring
  • diabetes
  • uveitis

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
corneal endothelium cell loss3 months

Corneal endothelium cells was evaluated by specular microskopy before and 3 month post-operatively.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Frederiksberg University Hospital

🇩🇰

Frederiksberg, Denmark

Frederiksberg University Hospital
🇩🇰Frederiksberg, Denmark

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.